| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | SCYNEXIS INC | 313,000 | 2,751,000 | 0.27% | ||
| 102 | Otonomy Inc | 113,000 | 2,598,000 | 0.25% | ||
| 103 | TREVENA INC | 410,000 | 2,567,000 | 0.25% | ||
| 104 | ELLOMAY CAPITAL LIMITED | 246,697 | 2,518,000 | 0.25% | ||
| 105 | SNAP ON INC | 15,340 | 2,443,000 | 0.24% | ||
| 106 | TOBIRA THERAPEUTICS INC | 137,622 | 2,374,000 | 0.23% | ||
| 107 | TETRAPHASE PHARMACEUTICALS INC COM | 49,500 | 2,348,000 | 0.23% | ||
| 108 | SUMMIT THERAPEUTICS PLC | 205,200 | 2,280,000 | 0.22% | ||
| 109 | PALATIN TECHNOLOGIES INC COM | 2,540,266 | 2,261,000 | 0.22% | ||
| 110 | WABTEC CORP | 22,365 | 2,108,000 | 0.21% | ||
| 111 | Aldeyra Therapeutics Inc | 265,000 | 2,056,000 | 0.20% | ||
| 112 | INOTEK PHARMACEUTICALS CORP | 380,000 | 1,862,000 | 0.18% | ||
| 113 | Former Charter Communication (Del 5/18/2016) | 10,065 | 1,724,000 | 0.17% | ||
| 114 | TOWERS WATSON & CO | 12,807 | 1,611,000 | 0.16% | ||
| 115 | EXELIXIS INC | 400,000 | 1,504,000 | 0.15% | ||
| 116 | APTOSE BIOSCIENCES INC | 221,096 | 1,415,000 | 0.14% | ||
| 117 | BROADCOM CORP CL A | 24,894 | 1,282,000 | 0.13% | ||
| 118 | V F CORP | 17,600 | 1,227,000 | 0.12% | ||
| 119 | Nice Systems LTD Sponsored | 18,250 | 1,161,000 | 0.11% | ||
| 120 | IMMUNOMEDICS INCORPORATED | 245,000 | 995,000 | 0.10% | ||
| 121 | GENVEC INC | 360,325 | 735,000 | 0.07% | ||
| 122 | IMPAX LABORATORIES INC | 15,000 | 689,000 | 0.07% | ||
| 123 | SAPIENS INTL CORP N V SHS NEW | 56,420 | 586,000 | 0.06% | ||
| 124 | CARA THERAPEUTICS INC | 46,700 | 567,000 | 0.06% | ||
| 125 | GALECTIN THERAPEUTICS INC COM | 205,000 | 560,000 | 0.05% | ||
| 126 | ZOSANO PHARMA CORP | 62,300 | 452,000 | 0.04% | ||
| 127 | AURIS MED HLDG AG | 63,967 | 316,000 | 0.03% | ||
| 128 | PERRIGO CO PLC | 273 | 246,000 | 0.02% | ||
| 129 | CONCERT PHARMACEUTICALS INCORPORATED | 15,858 | 236,000 | 0.02% | ||
| 130 | TRANSITION THERAPEUTICS INC | 70,273 | 148,000 | 0.01% | ||
| 131 | LUMENIS LTD | 245 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-15-002526, filed 2015.08.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
